Tuberculosis Program Evaluation and Research Unit, Department of Medicine, University of Alberta, Edmonton, AB.
Can J Public Health. 2010 May-Jun;101(3):202-4. doi: 10.1007/BF03404374.
Heretofore we have not seen strong evidence of synergy between HIV and tuberculosis (TB) in Canada. This may simply reflect a lack of concurrent surveillance for the two diseases. To date, the goal of universal HIV testing of TB patients (> 80% tested) in Canada has not been achieved, despite the existence of two national advisories recommending universal HIV testing of TB patients. In response to these advisories, we recently undertook to demonstrate the feasibility of using an 'opt-out' approach to achieve universal HIV testing of TB patients in Alberta--see the Canadian Journal of Public Health 2009;100(2):116-20. In the present commentary, we add two more years of data (2007-2008) to our earlier report and demonstrate for the first time that HIV co-infection is significantly greater in middle-aged (35-64 years) compared to young adult (15-34 years) TB patients and in Aboriginal and sub-Saharan African, compared to Canadian-born non-Aboriginal and foreign-born 'other' TB patients. Our findings underscore the need for universal concurrent testing as well as greater interaction between TB and HIV programs.
迄今为止,我们在加拿大尚未发现艾滋病毒与结核病(TB)之间有很强的协同作用的有力证据。这可能仅仅反映出对这两种疾病没有同时进行监测。尽管有两项国家咨询意见建议对所有结核病患者进行艾滋病毒检测,但加拿大仍未达到对所有结核病患者(检测率超过 80%)进行艾滋病毒检测的目标。为了回应这些咨询意见,我们最近着手证明在艾伯塔省采用“默认选择”方法对结核病患者进行艾滋病毒检测是可行的,详见《加拿大公共卫生杂志》2009 年第 100 卷第 2 期第 116-120 页。在本评论中,我们将我们早期报告中的数据增加了两年(2007-2008 年),首次证明艾滋病毒合并感染在中年(35-64 岁)结核病患者中明显高于青年(15-34 岁)结核病患者,在土著居民和撒哈拉以南非洲人,与加拿大出生的非土著居民和外国出生的“其他”结核病患者相比,艾滋病毒合并感染也明显更高。我们的发现强调了需要进行普遍的同时检测,以及加强结核病和艾滋病毒规划之间的互动。